Astera Labs, Inc. $ALAB Shares Bought by Diversified Trust Co

Diversified Trust Co grew its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 62.8% in the 1st quarter, HoldingsChannel.com reports. The firm owned 4,369 shares of the company’s stock after purchasing an additional 1,685 shares during the period. Diversified Trust Co’s holdings in Astera Labs were worth $479,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in ALAB. Assetmark Inc. lifted its stake in Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after purchasing an additional 101 shares during the last quarter. Reflection Asset Management acquired a new position in Astera Labs in the fourth quarter worth approximately $25,000. Smartleaf Asset Management LLC grew its position in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Hilltop National Bank grew its position in Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares during the last quarter. Finally, Aventura Private Wealth LLC bought a new position in shares of Astera Labs in the fourth quarter valued at $33,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 3,505 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total value of $1,277,046.75. Following the transaction, the director owned 60,134 shares in the company, valued at $21,909,822.90. The trade was a 5.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of the company’s stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $291.03, for a total value of $231,659.88. Following the completion of the transaction, the general counsel directly owned 103,343 shares in the company, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 2,161,256 shares of company stock valued at $459,844,296 in the last quarter. Corporate insiders own 10.40% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the company. Needham & Company LLC increased their price objective on Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Rothschild & Co Redburn initiated coverage on Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 target price on the stock. Barclays upped their target price on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Finally, Roth Mkm reiterated a “buy” rating and issued a $275.00 price target on shares of Astera Labs in a research report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $254.75.

Astera Labs Price Performance

ALAB stock opened at $398.00 on Friday. The firm has a market capitalization of $68.22 billion, a P/E ratio of 268.92, a P/E/G ratio of 4.59 and a beta of 3.95. Astera Labs, Inc. has a 52-week low of $85.85 and a 52-week high of $440.99. The company’s 50 day simple moving average is $284.80 and its 200-day simple moving average is $194.71.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business’s revenue for the quarter was up 93.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts predict that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.